Rockefeller Capital Management’s Invesco Biotechnology & Genome ETF PBE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $699K | Hold |
|
|||||
|
2025
Q2 | $641K | Hold |
|
|||||
|
2025
Q1 | $634K | Sell |
|
|||||
|
2024
Q4 | $667K | Hold |
|
|||||
|
2024
Q3 | $700K | Hold |
|
|||||
|
2024
Q2 | $649K | Hold |
|
|||||
|
2024
Q1 | $648K | Sell |
|
|||||
|
2023
Q4 | $662K | Buy |
|
|||||
|
2023
Q3 | $570K | Hold |
|
|||||
|
2023
Q2 | $613K | Hold |
|
|||||
|
2023
Q1 | $627K | Hold |
|
|||||
|
2022
Q4 | $634K | Hold |
|
|||||
|
2022
Q3 | $589K | Hold |
|
|||||
|
2022
Q2 | $577K | Hold |
|
|||||
|
2022
Q1 | $620K | Hold |
|
|||||
|
2021
Q4 | $712K | Hold |
|
|||||
|
2021
Q3 | $748K | Hold |
|
|||||
|
2021
Q2 | $773K | Hold |
|
|||||
|
2021
Q1 | $738K | Hold |
|
|||||
|
2020
Q4 | $701K | Buy |
|